Ex-vivo -chemoresponsetesting of head and neck cancer: An old hat?;Ex-vivo-Chemoresponsetestung von Kopf-Hals-Tumoren: Ein alter Hut?

Laryngo- Rhino- Otologie

Volumn 90, Issue 8, 2011, Pages 464-468

  Wichmann, G ^a   Krner, C ^a   Dietz, A ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Chemoresponse test; ex vivo; Flavino; HNSCC; predictive testing

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; EX VIVO STUDY; HEAD AND NECK CANCER; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INDIVIDUALIZED MEDICINE; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PATHOLOGIC; OTORHINOLARYNGOLOGIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; TISSUE CULTURE TECHNIQUES; TISSUE SCAFFOLDS; TUMOR STEM CELL ASSAY;

EID: 79961126766     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0031-1283137     Document Type: Review

References (11)

1. Dollner R, Granzow C, Helmke BM, Ruess A, Schad A, Dietz A. The impact of stromal cell contamination on chemosensitivity testing of head and neck carcinoma. Anticancer Res: 2004; 24 325 331 (Pubitemid 38279727)
2. Horn IS, Wichmann G, Mozet C, Dietz A, Dollner R, Tschp K, Boehm A. Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse. Cancer Chemother Pharmacol: 2010; 65 06 1153 1163
3. Mosmann T. A rapid colorimetric assay for cellular growth and cytotoxicity assays. J Immunol Methods: 1983; 65 55 63
4. Neubauer H, Stefanova M, Solomayer E, Meisner C, Zwirner M, Wallwiener D, Fehm T. Predicting resistance to platinum-containing chemotherapy with the ATP tumor chemosensitivity assay in primary ovarian cancer. Anticancer Res: 2008; 28 949 955 (Pubitemid 351578941)
5. Elprana D, Schwachofer J, Kuijpers W, van den Broek P, Wagener DJ. In vitro chemosensitivity testing of squamous cell carcinoma of the head neck. Acta Otolaryngol: 1987; 103 529 536 (Pubitemid 17088562)
6. Kern DH, Drogemuller CR, Kennedy MC, Hildebrand-Zanki SU, Tanigawa N, Sondak VK. Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors. Cancer Res: 1985; 45 5436 5441 (Pubitemid 16200800)
7. Von Hoff DD. Hes Not Going to Talk About In Vitro Predictive Assays Again, Is He? J Natl Cancer Inst: 1990; 82 96 101 (Pubitemid 20034339)
8. Dollner R, Granzow C, Werner JA, Dietz A. Is There a Role for Chemosensitivity Tests in Head and Neck Cancer? Onkologie: 2004; 27 310 315 (Pubitemid 39279343)
9. Wichmann G, Horn IS, Boehm A, Mozet C, Tschp K, Dollner R, Dietz A. Single Tissue Samples from Head and Neck Squamous Cell Carcinomas are Representative Regarding the Entire Tumors Chemosensitivity to Cisplatin and Docetaxel. Onkologie: 2009; 32 264 272
10. Singh B, Li R, Xu L, Poluri A, Patel S, Shaha AR, Pfister D, Sherman E, Goberdhan A, Hoffman RM, Shah J. Prediction of survival in patients with head and neck cancer using the histoculture drug response assay. Head Neck: 2002; 24 437 442 (Pubitemid 34506703)
11. Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U, Zipp F. Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet: 2000; 356 9232 827 828